Assignee
CLOUDBREAK THERAPEUTICS LLC
US·11 granted patents·4 pending applications·72 citations·filing 2016–2024
Top patents by PatentIndex Score
15 records- 0197US9987223B2Compositions and methods for treating pterygiumCLOUDBREAK THERAPEUTICS LLC·Filed 2017·Granted Jun 5, 2018·19 cites·24 claims
- 0297US9980901B2Compositions and methods for treating pterygiumCLOUDBREAK THERAPEUTICS LLC·Filed 2016·Granted May 29, 2018·16 cites·20 claims
- 0396US10149820B2Compositions and methods for treating pterygiumCLOUDBREAK THERAPEUTICS LLC·Filed 2018·Granted Dec 11, 2018·8 cites·11 claims
- 0495US10688092B2Compositions and methods of using nintedanib for improving glaucoma surgery successCLOUDBREAK THERAPEUTICS LLC·Filed 2019·Granted Jun 23, 2020·9 cites·27 claims
- 0594US10980741B2Compositions and methods for treating pterygium recurrenceCLOUDBREAK THERAPEUTICS LLC·Filed 2018·Granted Apr 20, 2021·5 cites·19 claims
- 0693US12186424B2Compositions and methods for treating pterygium recurrenceCLOUDBREAK THERAPEUTICS LLC·Filed 2021·Granted Jan 7, 2025·2 cites·6 claims
- 0792US10149819B2Compositions and methods for treating hyperemiaCLOUDBREAK THERAPEUTICS LLC·Filed 2018·Granted Dec 11, 2018·3 cites·11 claims
- 0891US11007214B2Compositions and methods for treating eye diseasesCLOUDBREAK THERAPEUTICS LLC·Filed 2020·Granted May 18, 2021·2 cites·10 claims
- 0990US10335408B2Compositions and methods of using nintedanib for improving glaucoma surgery successCLOUDBREAK THERAPEUTICS LLC·Filed 2018·Granted Jul 2, 2019·6 cites·27 claims
- 1088US2025262148A1Compositions and methods for treating pterygium recurrenceCLOUDBREAK THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 1187US11666533B2Emulsion formulations of multikinase inhibitorsCLOUDBREAK THERAPEUTICS LLC·Filed 2021·Granted Jun 6, 2023·1 cites·9 claims
- 1277US10744153B1Compositions and methods for treating meibomian gland dysfunctionCLOUDBREAK THERAPEUTICS LLC·Filed 2019·Granted Aug 18, 2020·1 cites·12 claims
- 1374US2023381103A1Emulsion formulations of multikinase inhibitorsCLOUDBREAK THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 1467US2021315815A1Emulsion formulations of multikinase inhibitorsCLOUDBREAK THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 1553US2022331310A1Methods for alleviating pterygium-associated worry about eye appearanceCLOUDBREAK THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →